Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L Responds to JAMA Keratitis Concerns, Seeks Multiplus Conversion

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb announced the launch of a new Wear & Care program Aug. 22 that seeks to educate consumers about the proper care of their contact lenses in response to an Aug. 23/30 Journal of the American Medical Association (JAMA) article on Fusarium keratitis

You may also be interested in...



Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings

Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year

Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings

Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year

Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings

Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel